Aviva’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,918
Closed -$1.42M 999
2021
Q1
$1.42M Sell
10,918
-7,009
-39% -$841K 0.01% 729
2020
Q4
$1.86M Sell
17,927
-14,536
-45% -$1.26M 0.01% 686
2020
Q3
$2.46M Sell
32,463
-16,865
-34% -$956K 0.01% 605
2020
Q2
$2.34M Sell
49,328
-57,928
-54% -$2.39M 0.01% 629
2020
Q1
$3.56M Buy
+107,256
New +$4.26M 0.03% 598

Other funds holding SWAV

Aviva's SWAV Position: Q2 2021 in Review

Aviva sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2021, closing a stake of 10,918 shares — an estimated $1.42M sold.

Aviva first reported a position in SWAV in Q1 2020 and held it in 5 quarters. The position peaked at $3.56M in Q1 2020. 240 funds tracked by Wall St. Rank hold SWAV as of Q2 2021.

  • Aviva reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Aviva sold 10,918 Shockwave Medical, Inc. Common Stock shares in Q2 2021, an estimated $1.42M.
  • Aviva first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
  • Aviva's Shockwave Medical, Inc. Common Stock position peaked at $3.56M in Q1 2020.
  • 240 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.